Skip to main content
Erschienen in: Breast Cancer Research 5/2000

01.10.2000 | Review

Estrogen receptor transcription and transactivation Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer

verfasst von: Benita S Katzenellenbogen, John A Katzenellenbogen

Erschienen in: Breast Cancer Research | Ausgabe 5/2000

Einloggen, um Zugang zu erhalten

Abstract

Estrogens display intriguing tissue-selective action that is of great biomedical importance in the development of optimal therapeutics for the prevention and treatment of breast cancer, for menopausal hormone replacement, and for fertility regulation. Certain compounds that act through the estrogen receptor (ER), now referred to as selective estrogen receptor modulators (SERMs), can demonstrate remarkable differences in activity in the various estrogen target tissues, functioning as agonists in some tissues but as antagonists in others. Recent advances elucidating the tripartite nature of the biochemical and molecular actions of estrogens provide a good basis for understanding these tissue-selective actions. As discussed in this thematic review, the development of optimal SERMs should now be viewed in the context of two estrogen receptor subtypes, ERα and ERβ, that have differing affinities and responsiveness to various SERMs, and differing tissue distribution and effectiveness at various gene regulatory sites. Cellular, biochemical, and structural approaches have also shown that the nature of the ligand affects the conformation assumed by the ER-ligand complex, thereby regulating its state of phosphorylation and the recruitment of different coregulator proteins. Growth factors and protein kinases that control the phosphorylation state of the complex also regulate the bioactivity of the ER. These interactions and changes determine the magnitude of the transcriptional response and the potency of different SERMs. As these critical components are becoming increasingly well defined, they provide a sound basis for the development of novel SERMs with optimal profiles of tissue selectivity as medical therapeutic agents.
Literatur
1.
Zurück zum Zitat McDonnell DP: The molecular pharmacology of SERMs. Trends Endocrinol Metab. 1999, 10: 301-311. 10.1016/S1043-2760(99)00177-0.PubMedCrossRef McDonnell DP: The molecular pharmacology of SERMs. Trends Endocrinol Metab. 1999, 10: 301-311. 10.1016/S1043-2760(99)00177-0.PubMedCrossRef
2.
Zurück zum Zitat Grese TA, Dodge JA: Selective estrogen receptor modulators (SERMS). Curr Pharmacol Design. 1998, 4: 71-92. Grese TA, Dodge JA: Selective estrogen receptor modulators (SERMS). Curr Pharmacol Design. 1998, 4: 71-92.
3.
Zurück zum Zitat Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998, 90: 1371-1388.This is an important summary of the findings of the large tamoxifen breastcancer prevention clinical trial, 10.1093/jnci/90.18.1371.PubMedCrossRef Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998, 90: 1371-1388.This is an important summary of the findings of the large tamoxifen breastcancer prevention clinical trial, 10.1093/jnci/90.18.1371.PubMedCrossRef
4.
Zurück zum Zitat Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC: The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA. 1999, 281: 2189-2197. 10.1001/jama.281.23.2189.PubMedCrossRef Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC: The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA. 1999, 281: 2189-2197. 10.1001/jama.281.23.2189.PubMedCrossRef
5.
Zurück zum Zitat Katzenellenbogen JA, O'Malley BW, Katzenellenbogen BS: Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol Endocrinol. 1996, 10: 119-131. 10.1210/me.10.2.119.PubMed Katzenellenbogen JA, O'Malley BW, Katzenellenbogen BS: Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol Endocrinol. 1996, 10: 119-131. 10.1210/me.10.2.119.PubMed
6.
Zurück zum Zitat Kuiper GJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA: Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA. 1996, 93: 5925-5930. 10.1073/pnas.93.12.5925, This is the first publication on the cloning of estrogen receptor beta in therat and indication of its high expression in ovary and prostate.PubMedPubMedCentralCrossRef Kuiper GJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA: Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA. 1996, 93: 5925-5930. 10.1073/pnas.93.12.5925, This is the first publication on the cloning of estrogen receptor beta in therat and indication of its high expression in ovary and prostate.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Mosselman S, Polman J, Dijkema R: ERβ : identification and characterization of a novel human estrogen receptor. FEBS Lett. 1996, 392: 49-53. 10.1016/0014-5793(96)00782-X, The first publication on the cloning of human estrogen receptor beta fromthe testis.PubMedCrossRef Mosselman S, Polman J, Dijkema R: ERβ : identification and characterization of a novel human estrogen receptor. FEBS Lett. 1996, 392: 49-53. 10.1016/0014-5793(96)00782-X, The first publication on the cloning of human estrogen receptor beta fromthe testis.PubMedCrossRef
8.
Zurück zum Zitat Nilsson S, Gustafsson J-A: Basic aspects of estrogen action. Breast Cancer Res. 2000. Nilsson S, Gustafsson J-A: Basic aspects of estrogen action. Breast Cancer Res. 2000.
9.
Zurück zum Zitat Kuiper GGJM, Carlsson B, Grandien J, Enmark E, Haggblad J, Nilsson S, Gustafsson JA: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology. 1997, 138: 863-870. 10.1210/en.138.3.863, An important study demonstrating the differences in affinity of some ligandsfor estrogen receptors alpha and beta, and the overlapping, but also distinct,tissue distribution of these receptor subtypesPubMed Kuiper GGJM, Carlsson B, Grandien J, Enmark E, Haggblad J, Nilsson S, Gustafsson JA: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology. 1997, 138: 863-870. 10.1210/en.138.3.863, An important study demonstrating the differences in affinity of some ligandsfor estrogen receptors alpha and beta, and the overlapping, but also distinct,tissue distribution of these receptor subtypesPubMed
10.
Zurück zum Zitat Makela S, Savolainen H, Aavik E, Myllarniemi M, Strauss L, Taskinen E, Gustafsson JA, Hayry P: Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta. Proc Natl Acad Sci USA. 1999, 96: 7077-7082. 10.1073/pnas.96.12.7077, A comparison of genistein versus estradiol, demonstrating target tissueselectivity of genistein in its vasculoprotective activity with minimal uterinestimulatory activity.PubMedPubMedCentralCrossRef Makela S, Savolainen H, Aavik E, Myllarniemi M, Strauss L, Taskinen E, Gustafsson JA, Hayry P: Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta. Proc Natl Acad Sci USA. 1999, 96: 7077-7082. 10.1073/pnas.96.12.7077, A comparison of genistein versus estradiol, demonstrating target tissueselectivity of genistein in its vasculoprotective activity with minimal uterinestimulatory activity.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat McInerney EM, Katzenellenbogen BS: Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation. J Biol Chem. 1996, 271: 24172-24178. 10.1074/jbc.271.39.24172,An analysis of ERa demonstrating that different regions of activation function1 support the agonistic activity of tamoxifen and estradiolPubMedCrossRef McInerney EM, Katzenellenbogen BS: Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation. J Biol Chem. 1996, 271: 24172-24178. 10.1074/jbc.271.39.24172,An analysis of ERa demonstrating that different regions of activation function1 support the agonistic activity of tamoxifen and estradiolPubMedCrossRef
12.
Zurück zum Zitat McInerney EM, Weis KE, Sun J, Mosselman S, Katzenellenbogen BS: Transcription activation by the human estrogen receptor subtypeβ (ERβ) studied with ERβ and ERα receptor chimeras. Endocrinology. 1998, 139: 4513-4522. 10.1210/en.139.11.4513.PubMed McInerney EM, Weis KE, Sun J, Mosselman S, Katzenellenbogen BS: Transcription activation by the human estrogen receptor subtypeβ (ERβ) studied with ERβ and ERα receptor chimeras. Endocrinology. 1998, 139: 4513-4522. 10.1210/en.139.11.4513.PubMed
13.
Zurück zum Zitat Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F, Giguere V: Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β. Mol Endocrinol. 1997, 11: 353-365. 10.1210/me.11.3.353.PubMed Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F, Giguere V: Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β. Mol Endocrinol. 1997, 11: 353-365. 10.1210/me.11.3.353.PubMed
14.
Zurück zum Zitat Sun J, Meyers MJ, Fink BE, Rajendran R, Katzenellenbogen JA, Katzenellenbogen BS: Novel ligands that function as selective estrogens or anti-estrogens for estrogen receptor-α or estrogen receptor-β. Endocrinology. 1999, 140: 800-804. 10.1210/en.140.2.800, This is the first report on ligands that are highly selective for one of the twoestrogen receptor subtypes, and the identification of a selective ERbantagonist ligand.PubMed Sun J, Meyers MJ, Fink BE, Rajendran R, Katzenellenbogen JA, Katzenellenbogen BS: Novel ligands that function as selective estrogens or anti-estrogens for estrogen receptor-α or estrogen receptor-β. Endocrinology. 1999, 140: 800-804. 10.1210/en.140.2.800, This is the first report on ligands that are highly selective for one of the twoestrogen receptor subtypes, and the identification of a selective ERbantagonist ligand.PubMed
15.
Zurück zum Zitat Stauffer SR, Sun J, Katzenellenbogen BS, Katzenellenbogen JA: Acyclic amides as estrogen receptor ligands. Bioorg Med Chem. 2000. Stauffer SR, Sun J, Katzenellenbogen BS, Katzenellenbogen JA: Acyclic amides as estrogen receptor ligands. Bioorg Med Chem. 2000.
16.
Zurück zum Zitat Meyers MJ, Sun J, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA: Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl-5,6,11,12-tetrahydrochrysenes. J Med Chem. 1999, 42: 2456-2468. 10.1021/jm990101b, A study of structure–activity relationships in a novel nonsteroidal ligandsystem, demonstrating that substituent size and stereochemistry regulateERb antagonist activity.PubMedCrossRef Meyers MJ, Sun J, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA: Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl-5,6,11,12-tetrahydrochrysenes. J Med Chem. 1999, 42: 2456-2468. 10.1021/jm990101b, A study of structure–activity relationships in a novel nonsteroidal ligandsystem, demonstrating that substituent size and stereochemistry regulateERb antagonist activity.PubMedCrossRef
17.
Zurück zum Zitat Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O, Ljunggren J, Gustafsson J, Carlquist M: Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J. 1999, 18: 4608-4618. 10.1093/emboj/18.17.4608, The first X-ray crystal structure of the hormone binding domain of ERb.PubMedPubMedCentralCrossRef Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O, Ljunggren J, Gustafsson J, Carlquist M: Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J. 1999, 18: 4608-4618. 10.1093/emboj/18.17.4608, The first X-ray crystal structure of the hormone binding domain of ERb.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Ekena KE, Weis KE, Katzenellenbogen JA, Katzenellenbogen BS: Identification of amino acids in the hormone binding domain of the human estrogen receptor important in estrogen binding. J Biol Chem . 1996, 271: 20053-20059. 10.1074/jbc.271.33.20053.PubMedCrossRef Ekena KE, Weis KE, Katzenellenbogen JA, Katzenellenbogen BS: Identification of amino acids in the hormone binding domain of the human estrogen receptor important in estrogen binding. J Biol Chem . 1996, 271: 20053-20059. 10.1074/jbc.271.33.20053.PubMedCrossRef
19.
Zurück zum Zitat Ekena K, Weis KE, Katzenellenbogen JA, Katzenellenbogen BS: Different residues of the human estrogen receptor are involved in the recognition of structurally diverse estrogens and antiestrogens. J Biol Chem. 1997, 272: 5069-5075. 10.1074/jbc.272.8.5069,A study using alanine scanning mutagenesis demonstrating that differentestrogens have a different pattern of contact residues in helix-11 of ERa.This report also defined the orientation of estrogens in the ligand bindingpocket, with the steroid D-ring contacting helix-11.PubMedCrossRef Ekena K, Weis KE, Katzenellenbogen JA, Katzenellenbogen BS: Different residues of the human estrogen receptor are involved in the recognition of structurally diverse estrogens and antiestrogens. J Biol Chem. 1997, 272: 5069-5075. 10.1074/jbc.272.8.5069,A study using alanine scanning mutagenesis demonstrating that differentestrogens have a different pattern of contact residues in helix-11 of ERa.This report also defined the orientation of estrogens in the ligand bindingpocket, with the steroid D-ring contacting helix-11.PubMedCrossRef
20.
Zurück zum Zitat McDonnell DP, Clemm DL, Hermann T, Goldman ME, Pike JW: Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol. 1995, 9: 659-669. 10.1210/me.9.6.659,A study showing a spectrum in degree of estrogen antagonism of differentantiestrogens that reflected conformational changes in the ERa–antiestrogencomplex.PubMed McDonnell DP, Clemm DL, Hermann T, Goldman ME, Pike JW: Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol. 1995, 9: 659-669. 10.1210/me.9.6.659,A study showing a spectrum in degree of estrogen antagonism of differentantiestrogens that reflected conformational changes in the ERa–antiestrogencomplex.PubMed
21.
Zurück zum Zitat Lazennec G, Ediger TR, Petz LN, Nardulli AM, Katzenellenbogen BS: Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes. Mol Endocrinol. 1997, 11: 1375-1386. 10.1210/me.11.9.1375.PubMedCrossRef Lazennec G, Ediger TR, Petz LN, Nardulli AM, Katzenellenbogen BS: Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes. Mol Endocrinol. 1997, 11: 1375-1386. 10.1210/me.11.9.1375.PubMedCrossRef
22.
Zurück zum Zitat Allan GF, Leng X, Tsai SY, Weigel NL, Edwards DP, Tsai MJ, O'Malley GW: Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J Biol Chem. 1992, 267: 19513-19520.PubMed Allan GF, Leng X, Tsai SY, Weigel NL, Edwards DP, Tsai MJ, O'Malley GW: Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J Biol Chem. 1992, 267: 19513-19520.PubMed
23.
Zurück zum Zitat Paige LA, Christensen DJ, Gron H, Norris JD, Gottlin EB, Padilla KM, Chang C, Ballas LM, Hamilton PT, McDonnell DP, Fowlkes DM: Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. Proc Natl Acad Sci USA. 1999, 96: 3999-4004. 10.1073/pnas.96.7.3999, A novel study that used a peptide phage display library approach to identifydifferences in the conformation of ERa and ERb when complexed with differentagonist and antagonist ligands.PubMedPubMedCentralCrossRef Paige LA, Christensen DJ, Gron H, Norris JD, Gottlin EB, Padilla KM, Chang C, Ballas LM, Hamilton PT, McDonnell DP, Fowlkes DM: Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. Proc Natl Acad Sci USA. 1999, 96: 3999-4004. 10.1073/pnas.96.7.3999, A novel study that used a peptide phage display library approach to identifydifferences in the conformation of ERa and ERb when complexed with differentagonist and antagonist ligands.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Norris JD, Paige LA, Christensen DJ, Chang CY, Huacani MR, Fan D, Hamilton PT, Fowlkes DM, McDonnell DP: Peptide antagonists of the human estrogen receptor. Science. 1999, 285: 744-746. 10.1126/science.285.5428.744, An interesting application of conformation-selective peptides to block the agonisticactivity of tamoxifen, without affecting the agonistic activity of estradiol.PubMedCrossRef Norris JD, Paige LA, Christensen DJ, Chang CY, Huacani MR, Fan D, Hamilton PT, Fowlkes DM, McDonnell DP: Peptide antagonists of the human estrogen receptor. Science. 1999, 285: 744-746. 10.1126/science.285.5428.744, An interesting application of conformation-selective peptides to block the agonisticactivity of tamoxifen, without affecting the agonistic activity of estradiol.PubMedCrossRef
25.
Zurück zum Zitat Chang C, Norris JD, Gron H, Paige LA, Hamilton PT, Kenan DJ, Fowlkes D, McDonnell DP: Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta. Mol Cell Biol. 1999, 19: 8226-8239.PubMedPubMedCentralCrossRef Chang C, Norris JD, Gron H, Paige LA, Hamilton PT, Kenan DJ, Fowlkes D, McDonnell DP: Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta. Mol Cell Biol. 1999, 19: 8226-8239.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Rosati RL, Jardine PD, Cameron KO, Thompson DD, Ke HZ, Toler SM, Brown TA, Pan LC, Ebbinghaus CF, Reinhold AR, Elliott NC, Newhouse BN, Tjoa CM, Sweetnam PM, Cole MJ, Arriola MW, Gauthier JW, Crawford DT, Nickerson DF, Pirie CM, Qi H, Simmons HA, Tkalcevic GT: Discovery and preclinical pharmacology of a novel, potent, nonsteroidal estrogen receptor agonist/antagonist, Cp-336156 a diaryltetrahydronaphthalene. J Med Chem. 1998, 41: 2928-2931. 10.1021/jm980048b.PubMedCrossRef Rosati RL, Jardine PD, Cameron KO, Thompson DD, Ke HZ, Toler SM, Brown TA, Pan LC, Ebbinghaus CF, Reinhold AR, Elliott NC, Newhouse BN, Tjoa CM, Sweetnam PM, Cole MJ, Arriola MW, Gauthier JW, Crawford DT, Nickerson DF, Pirie CM, Qi H, Simmons HA, Tkalcevic GT: Discovery and preclinical pharmacology of a novel, potent, nonsteroidal estrogen receptor agonist/antagonist, Cp-336156 a diaryltetrahydronaphthalene. J Med Chem. 1998, 41: 2928-2931. 10.1021/jm980048b.PubMedCrossRef
27.
Zurück zum Zitat Willson TM, Norris JD, Wagner BL, Asplin I, Baer P, Brown HR, Jones SA, Henke B, Sauls H, Wolfe S, Morris DC, McDonnell DP: Dissection of the molecular mechanism of action of GW, a novel estrogen receptor ligand, provides insights into the role of estrogen receptor in bone. Endocrinology. 1997, 138: 3901-3911. 10.1210/en.138.9.3901.PubMed Willson TM, Norris JD, Wagner BL, Asplin I, Baer P, Brown HR, Jones SA, Henke B, Sauls H, Wolfe S, Morris DC, McDonnell DP: Dissection of the molecular mechanism of action of GW, a novel estrogen receptor ligand, provides insights into the role of estrogen receptor in bone. Endocrinology. 1997, 138: 3901-3911. 10.1210/en.138.9.3901.PubMed
28.
Zurück zum Zitat Baracat E, Haidar M, Lopez FJ, Pickar J, Dey M, Negro-Vilar A: Estrogen activity and novel tissue selectivity of Δ8,9dehydroestrone sulfate in postmenopausal women. J Clin Endocrinol Metab. 1999, 84: 2020-2027. 10.1210/jc.84.6.2020, An interesting study in women demonstrating that B-ring modified estrogenshave distinct tissue-selective actions.PubMed Baracat E, Haidar M, Lopez FJ, Pickar J, Dey M, Negro-Vilar A: Estrogen activity and novel tissue selectivity of Δ8,9dehydroestrone sulfate in postmenopausal women. J Clin Endocrinol Metab. 1999, 84: 2020-2027. 10.1210/jc.84.6.2020, An interesting study in women demonstrating that B-ring modified estrogenshave distinct tissue-selective actions.PubMed
29.
Zurück zum Zitat Hyder SM, Chiappetta C, Stancel GM: Interaction of human estrogen receptors alpha and beta with the same naturally occurring estrogen response elements. Biochem Pharmacol. 1999, 57: 597-601. 10.1016/S0006-2952(98)00355-4.PubMedCrossRef Hyder SM, Chiappetta C, Stancel GM: Interaction of human estrogen receptors alpha and beta with the same naturally occurring estrogen response elements. Biochem Pharmacol. 1999, 57: 597-601. 10.1016/S0006-2952(98)00355-4.PubMedCrossRef
30.
Zurück zum Zitat Lefstin JA, Yamamoto KR: Allosteric effects of DNA on transcriptional regulators. Nature. 1998, 392: 885-888. 10.1038/31860.PubMedCrossRef Lefstin JA, Yamamoto KR: Allosteric effects of DNA on transcriptional regulators. Nature. 1998, 392: 885-888. 10.1038/31860.PubMedCrossRef
31.
Zurück zum Zitat Wood JR, Greene GL, Nardulli AM: Estrogen response elements function as allosteric modulators of estrogen receptor conformation. Mol Cell Biol. 1998, 18: 1927-1934.PubMedPubMedCentralCrossRef Wood JR, Greene GL, Nardulli AM: Estrogen response elements function as allosteric modulators of estrogen receptor conformation. Mol Cell Biol. 1998, 18: 1927-1934.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson J-A, Kushner PJ, Scanlan TS: Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science. 1997, 277: 1508-1510. 10.1126/science.277.5331.1508, A study demonstrating that estrogens and antiestrogens show differentlevels of agonist versus antagonist activity at different gene sites, throughERa and ERb.PubMedCrossRef Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson J-A, Kushner PJ, Scanlan TS: Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science. 1997, 277: 1508-1510. 10.1126/science.277.5331.1508, A study demonstrating that estrogens and antiestrogens show differentlevels of agonist versus antagonist activity at different gene sites, throughERa and ERb.PubMedCrossRef
33.
Zurück zum Zitat Webb P, Nguyen P, Valentine C, Lopez GN, Kwok GR, McInerney E, Katzenellenbogen BS, Enmark E, Gustafsson JA, Nilsson S, Kushner PJ: The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol Endocrinol. 1999, 13: 1672-1685. 10.1210/me.13.10.1672.PubMedCrossRef Webb P, Nguyen P, Valentine C, Lopez GN, Kwok GR, McInerney E, Katzenellenbogen BS, Enmark E, Gustafsson JA, Nilsson S, Kushner PJ: The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol Endocrinol. 1999, 13: 1672-1685. 10.1210/me.13.10.1672.PubMedCrossRef
34.
Zurück zum Zitat Montano MM, Katzenellenbogen BS: The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens. Proc Natl Acad Sci USA. 1997, 94: 2581-2586. 10.1073/pnas.94.6.2581, A study documenting that quinone reductase, an antioxidant, chemoprotectivegene, is regulated by estrogens and antiestrogens with ‘reversed pharmacology’,being upregulated by antiestrogens, with this action blocked byestrogens. Antiestrogen regulation was shown to require functional ER andto be mediated via the electrophile response element region of the quinonereductase gene.PubMedPubMedCentralCrossRef Montano MM, Katzenellenbogen BS: The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens. Proc Natl Acad Sci USA. 1997, 94: 2581-2586. 10.1073/pnas.94.6.2581, A study documenting that quinone reductase, an antioxidant, chemoprotectivegene, is regulated by estrogens and antiestrogens with ‘reversed pharmacology’,being upregulated by antiestrogens, with this action blocked byestrogens. Antiestrogen regulation was shown to require functional ER andto be mediated via the electrophile response element region of the quinonereductase gene.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Montano MM, Jaiswal AK, Katzenellenbogen BS: Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-α and estrogen receptor-β. J Biol Chem. 1998, 273: 25443-25449. 10.1074/jbc.273.39.25443.PubMedCrossRef Montano MM, Jaiswal AK, Katzenellenbogen BS: Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-α and estrogen receptor-β. J Biol Chem. 1998, 273: 25443-25449. 10.1074/jbc.273.39.25443.PubMedCrossRef
36.
Zurück zum Zitat Yang NN, Venugopalan M, Hardikar S, Glasebrook A: Identification of an estrogen response element activated by metabolites of 17-β-estradiol and raloxifene. Science. 1996, 273: 1222-1225, An early demonstration that ERa can activate genes when tethered to aresponse element through other proteins. In this system, certain antiestrogensand estradiol metabolites were especially potent, more so than estradiol.PubMedCrossRef Yang NN, Venugopalan M, Hardikar S, Glasebrook A: Identification of an estrogen response element activated by metabolites of 17-β-estradiol and raloxifene. Science. 1996, 273: 1222-1225, An early demonstration that ERa can activate genes when tethered to aresponse element through other proteins. In this system, certain antiestrogensand estradiol metabolites were especially potent, more so than estradiol.PubMedCrossRef
37.
Zurück zum Zitat Tora L, White J, Brou C, Tassett D, Webster N, Scheer E, Chambon P: The human estrogen receptor has two independent transcriptional nonacidic activation functions. Cell. 1989, 59: 477-487, The first demonstration that two separable activation functions are presentin ERa and mediate its transcriptional activity. This study laid the groundworkfor many subsequent investigations.PubMedCrossRef Tora L, White J, Brou C, Tassett D, Webster N, Scheer E, Chambon P: The human estrogen receptor has two independent transcriptional nonacidic activation functions. Cell. 1989, 59: 477-487, The first demonstration that two separable activation functions are presentin ERa and mediate its transcriptional activity. This study laid the groundworkfor many subsequent investigations.PubMedCrossRef
38.
Zurück zum Zitat Bocquel MT, Kumar V, Chambon P, Gronemeyer H: The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell specific. Nucl Acids Res. 1989, 17: 2581-2595.PubMedPubMedCentralCrossRef Bocquel MT, Kumar V, Chambon P, Gronemeyer H: The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell specific. Nucl Acids Res. 1989, 17: 2581-2595.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Tzukerman MT, Esty A, Santiso-Mere D, Danielian P, Parker MG, Stein RB, Pike JW, McDonnell DP: Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol. 1994, 8: 21-30. 10.1210/me.8.1.21.PubMed Tzukerman MT, Esty A, Santiso-Mere D, Danielian P, Parker MG, Stein RB, Pike JW, McDonnell DP: Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol. 1994, 8: 21-30. 10.1210/me.8.1.21.PubMed
40.
Zurück zum Zitat Shim W-S, DiRenzo J, DeCaprio JA, Santen RJ, Brown M, Jeng M-H: Segregation of steroid receptor coactivator-1 from steroid receptors in mammary epithelium. Proc Natl Acad Sci USA. 1999, 96: 208-213. 10.1073/pnas.96.1.208.PubMedPubMedCentralCrossRef Shim W-S, DiRenzo J, DeCaprio JA, Santen RJ, Brown M, Jeng M-H: Segregation of steroid receptor coactivator-1 from steroid receptors in mammary epithelium. Proc Natl Acad Sci USA. 1999, 96: 208-213. 10.1073/pnas.96.1.208.PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Kraus WL, McInerney EM, Katzenellenbogen BS: Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor. Proc Natl Acad Sci USA. 1995, 92: 12314-12318.PubMedPubMedCentralCrossRef Kraus WL, McInerney EM, Katzenellenbogen BS: Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor. Proc Natl Acad Sci USA. 1995, 92: 12314-12318.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat McInerney EM, Tsai MJ, O'Malley BW, Katzenellenbogen BS: Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. Proc Natl Acad Sci USA. 1996, 93: 10069-10073. 10.1073/pnas.93.19.10069.PubMedPubMedCentralCrossRef McInerney EM, Tsai MJ, O'Malley BW, Katzenellenbogen BS: Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. Proc Natl Acad Sci USA. 1996, 93: 10069-10073. 10.1073/pnas.93.19.10069.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Shibata H, Spencer TE, Onate SA, Jenster G, Tsai SY, Tsai M-J, O'Malley BW: Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog Horm Res. 1997, 52: 141-165.PubMed Shibata H, Spencer TE, Onate SA, Jenster G, Tsai SY, Tsai M-J, O'Malley BW: Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog Horm Res. 1997, 52: 141-165.PubMed
44.
Zurück zum Zitat Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS: Nuclear receptor coactivators and corepressors. Mol Endocrinol. 1996, 10: 1167-1177. 10.1210/me.10.10.1167.PubMed Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS: Nuclear receptor coactivators and corepressors. Mol Endocrinol. 1996, 10: 1167-1177. 10.1210/me.10.10.1167.PubMed
45.
Zurück zum Zitat Glass CK, Rose DW, Rosenfeld MG: Nuclear receptor coactivators. Curr Opin Cell Biol. 1997, 9: 222-232. 10.1016/S0955-0674(97)80066-X.PubMedCrossRef Glass CK, Rose DW, Rosenfeld MG: Nuclear receptor coactivators. Curr Opin Cell Biol. 1997, 9: 222-232. 10.1016/S0955-0674(97)80066-X.PubMedCrossRef
46.
Zurück zum Zitat McKenna NJ, Lanz RB, O'Malley BW: Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev. 1999, 20: 321-344. 10.1210/er.20.3.321.PubMed McKenna NJ, Lanz RB, O'Malley BW: Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev. 1999, 20: 321-344. 10.1210/er.20.3.321.PubMed
47.
Zurück zum Zitat Glass CK, Rosenfeld MG: The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 2000, 14: 121-141.PubMed Glass CK, Rosenfeld MG: The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 2000, 14: 121-141.PubMed
48.
Zurück zum Zitat Gee AC, Carlson KE, Martini PG, Katzenellenbogen BS, Katzenellenbogen JA: Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor. Mol Endocrinol. 1999, 13: 1912-1923. 10.1210/me.13.11.1912.PubMedCrossRef Gee AC, Carlson KE, Martini PG, Katzenellenbogen BS, Katzenellenbogen JA: Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor. Mol Endocrinol. 1999, 13: 1912-1923. 10.1210/me.13.11.1912.PubMedCrossRef
49.
Zurück zum Zitat Szapary D, Huang Y, Simons SS: Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression. Mol Endocrinol. 1999, 13: 2108-2121. 10.1210/me.13.12.2108.PubMedCrossRef Szapary D, Huang Y, Simons SS: Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression. Mol Endocrinol. 1999, 13: 2108-2121. 10.1210/me.13.12.2108.PubMedCrossRef
50.
Zurück zum Zitat Onate SA, Tsai SY, Tsai MJ, O'Malley BW: Sequence and characterization of a coactivator for the steroid hormone receptor super family. Science. 1995, 270: 1354-1357.PubMedCrossRef Onate SA, Tsai SY, Tsai MJ, O'Malley BW: Sequence and characterization of a coactivator for the steroid hormone receptor super family. Science. 1995, 270: 1354-1357.PubMedCrossRef
51.
Zurück zum Zitat Montano MM, Ekena K, Delage-Mourroux R, Chang W, Martini P, Katzenellenbogen BS: An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens. Proc Natl Acad Sci USA. 1999, 96: 6947-6952. 10.1073/pnas.96.12.6947.PubMedPubMedCentralCrossRef Montano MM, Ekena K, Delage-Mourroux R, Chang W, Martini P, Katzenellenbogen BS: An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens. Proc Natl Acad Sci USA. 1999, 96: 6947-6952. 10.1073/pnas.96.12.6947.PubMedPubMedCentralCrossRef
52.
Zurück zum Zitat Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan X-Y, Sauter G, Kallioniemi O-P, Trent JM, Meltzer PS: AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science. 1997, 277: 965-968. 10.1126/science.277.5328.965.PubMedCrossRef Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan X-Y, Sauter G, Kallioniemi O-P, Trent JM, Meltzer PS: AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science. 1997, 277: 965-968. 10.1126/science.277.5328.965.PubMedCrossRef
53.
Zurück zum Zitat Smith CL, Nawaz Z, O'Malley BW: Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol Endocrinol. 1997, 11: 657-666. 10.1210/me.11.6.657.PubMedCrossRef Smith CL, Nawaz Z, O'Malley BW: Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol Endocrinol. 1997, 11: 657-666. 10.1210/me.11.6.657.PubMedCrossRef
54.
Zurück zum Zitat Lavinsky RM, Jepsen K, Heinzel T, Torchia J, Mullen T-M, Schiff R, Del-Rio AL, Ricote M, Ngo S, Gemsch J, Hilsenbeck SG, Osborne CK, Glass CK, Rosenfeld MG, Rose DW: Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc Natl Acad Sci USA. 1998, 95: 2920-2925. 10.1073/pnas.95.6.2920.PubMedPubMedCentralCrossRef Lavinsky RM, Jepsen K, Heinzel T, Torchia J, Mullen T-M, Schiff R, Del-Rio AL, Ricote M, Ngo S, Gemsch J, Hilsenbeck SG, Osborne CK, Glass CK, Rosenfeld MG, Rose DW: Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc Natl Acad Sci USA. 1998, 95: 2920-2925. 10.1073/pnas.95.6.2920.PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat Jackson TA, Richer J, Bain DL, Takimoto GS, Tung L, Horwitz KB: The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Mol Endocrinol. 1997, 11: 693-705. 10.1210/me.11.6.693.PubMedCrossRef Jackson TA, Richer J, Bain DL, Takimoto GS, Tung L, Horwitz KB: The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Mol Endocrinol. 1997, 11: 693-705. 10.1210/me.11.6.693.PubMedCrossRef
56.
Zurück zum Zitat Korzus E, Torchia J, Rose DW, Xu L, Kurokawa R, McInerney EM, Mullen T-M, Glass CK, Rosenfeld MG: Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science. 1998, 279: 703-707. 10.1126/science.279.5351.703.PubMedCrossRef Korzus E, Torchia J, Rose DW, Xu L, Kurokawa R, McInerney EM, Mullen T-M, Glass CK, Rosenfeld MG: Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science. 1998, 279: 703-707. 10.1126/science.279.5351.703.PubMedCrossRef
57.
Zurück zum Zitat Kraichely DM, Sun J, Katzenellenbogen JA, Katzenellenbogen BS: Conformational changes and coactivator recruitment by novel ligands for estrogen receptor alpha and estrogen receptor beta: Correlations with biological character and distinct differences among SRC coactivator family members. Endocrinology. 2000. Kraichely DM, Sun J, Katzenellenbogen JA, Katzenellenbogen BS: Conformational changes and coactivator recruitment by novel ligands for estrogen receptor alpha and estrogen receptor beta: Correlations with biological character and distinct differences among SRC coactivator family members. Endocrinology. 2000.
58.
Zurück zum Zitat Cowley SM, Hoare S, Mosselman S, Parker MG: Estrogen receptors α and β form heterodimers on DNA. J Biol Chem. 1997, 272: 19858-19862. 10.1074/jbc.272.32.19858.PubMedCrossRef Cowley SM, Hoare S, Mosselman S, Parker MG: Estrogen receptors α and β form heterodimers on DNA. J Biol Chem. 1997, 272: 19858-19862. 10.1074/jbc.272.32.19858.PubMedCrossRef
59.
Zurück zum Zitat Pace P, Taylor J, Suntharalingam S, Coombes RC, Ali S: Human estrogen receptor beta binds DNA in a similar to and dimerizes with estrogen receptor alpha. J Biol Chem. 1997, 272: 25832-25838. 10.1074/jbc.272.41.25832.PubMedCrossRef Pace P, Taylor J, Suntharalingam S, Coombes RC, Ali S: Human estrogen receptor beta binds DNA in a similar to and dimerizes with estrogen receptor alpha. J Biol Chem. 1997, 272: 25832-25838. 10.1074/jbc.272.41.25832.PubMedCrossRef
60.
Zurück zum Zitat Vladusic EA, Hornby AE, Guerra-Vladusic FK, Lupu R: Expression of estrogen receptor β messenger RNA variant in breast cancer. Cancer Res. 1998, 58: 210-214.PubMed Vladusic EA, Hornby AE, Guerra-Vladusic FK, Lupu R: Expression of estrogen receptor β messenger RNA variant in breast cancer. Cancer Res. 1998, 58: 210-214.PubMed
61.
Zurück zum Zitat Dotzlaw H, Leygue E, Watson PH, Murphy LC: Expression of estrogen receptor-β in human breast tumors. J Clin Endocrinol Metab. 1997, 82: 2371-2377. 10.1210/jc.82.7.2371.PubMed Dotzlaw H, Leygue E, Watson PH, Murphy LC: Expression of estrogen receptor-β in human breast tumors. J Clin Endocrinol Metab. 1997, 82: 2371-2377. 10.1210/jc.82.7.2371.PubMed
62.
Zurück zum Zitat Leygue E, Dotzlaw H, Watson PH, Murphy LC: Altered estrogen receptor α and β messenger RNA expression during human breast tumorigenesis. Cancer Res. 1998, 58: 3197-3201.PubMed Leygue E, Dotzlaw H, Watson PH, Murphy LC: Altered estrogen receptor α and β messenger RNA expression during human breast tumorigenesis. Cancer Res. 1998, 58: 3197-3201.PubMed
63.
Zurück zum Zitat Zhang Q-X, Hilsenbeck SG, Fuqua SAW, Borg A: Multiple splicing variants of the estrogen receptor are present in individual human breast tumors. J Steroid Biochem Mol Biol. 1996, 59: 251-260. 10.1016/S0960-0760(96)00120-3.PubMedCrossRef Zhang Q-X, Hilsenbeck SG, Fuqua SAW, Borg A: Multiple splicing variants of the estrogen receptor are present in individual human breast tumors. J Steroid Biochem Mol Biol. 1996, 59: 251-260. 10.1016/S0960-0760(96)00120-3.PubMedCrossRef
64.
Zurück zum Zitat Hall JM, McDonnell DP: The estrogen receptor beta-isoform (ERβ) of the human estrogen receptor modulates ER alpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology. 1999, 140: 5566-5578. 10.1210/en.140.12.5566.PubMed Hall JM, McDonnell DP: The estrogen receptor beta-isoform (ERβ) of the human estrogen receptor modulates ER alpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology. 1999, 140: 5566-5578. 10.1210/en.140.12.5566.PubMed
65.
Zurück zum Zitat Herman ME, Katzenellenbogen BS: Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen. J Steroid Biochem Mol Biol. 1996, 59: 121-134. 10.1016/S0960-0760(96)00114-8.PubMedCrossRef Herman ME, Katzenellenbogen BS: Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen. J Steroid Biochem Mol Biol. 1996, 59: 121-134. 10.1016/S0960-0760(96)00114-8.PubMedCrossRef
66.
Zurück zum Zitat Karnik PS, Kulkarni S, Liu X, Budd GT, Bukowski RM: Estrogen receptor mutation in tamoxifen-resistant breast cancer. Cancer Res . 1994, 54: 349-353.PubMed Karnik PS, Kulkarni S, Liu X, Budd GT, Bukowski RM: Estrogen receptor mutation in tamoxifen-resistant breast cancer. Cancer Res . 1994, 54: 349-353.PubMed
67.
Zurück zum Zitat Wolf DM, Jordan VC: Characterization of tamoxifen stimulated MCF-7 tumor variants grown in athymic mice. Breast Cancer Res Treat . 1994, 31: 117-127.PubMedCrossRef Wolf DM, Jordan VC: Characterization of tamoxifen stimulated MCF-7 tumor variants grown in athymic mice. Breast Cancer Res Treat . 1994, 31: 117-127.PubMedCrossRef
68.
Zurück zum Zitat Levenson AS, Jordan VC: The key to the antiestrogenic mechanism of raloxifene is amino acid 351 (aspartate) in the estrogen receptor. Cancer Res. 1998, 58: 1872-1875.PubMed Levenson AS, Jordan VC: The key to the antiestrogenic mechanism of raloxifene is amino acid 351 (aspartate) in the estrogen receptor. Cancer Res. 1998, 58: 1872-1875.PubMed
69.
Zurück zum Zitat Katzenellenbogen BS, Montano MM, Ekena K, Herman ME, McInerney EM: Antiestrogens: mechanisms of action and resistance in breast cancer. Breast Cancer Res Treat. 1997, 44: 23-38. 10.1023/A:1005835428423.PubMedCrossRef Katzenellenbogen BS, Montano MM, Ekena K, Herman ME, McInerney EM: Antiestrogens: mechanisms of action and resistance in breast cancer. Breast Cancer Res Treat. 1997, 44: 23-38. 10.1023/A:1005835428423.PubMedCrossRef
70.
Zurück zum Zitat Morrow M, Jordan VC: Molecular mechanisms of resistance to tamoxifen therapy in breast cancer. Arch Surg. 1993, 128: 1187-1191.PubMedCrossRef Morrow M, Jordan VC: Molecular mechanisms of resistance to tamoxifen therapy in breast cancer. Arch Surg. 1993, 128: 1187-1191.PubMedCrossRef
71.
Zurück zum Zitat Osborne CK, Fuqua SAW: Mechanisms of tamoxifen resistance. Breast Cancer Res Treat. 1994, 32: 49-55.PubMedCrossRef Osborne CK, Fuqua SAW: Mechanisms of tamoxifen resistance. Breast Cancer Res Treat. 1994, 32: 49-55.PubMedCrossRef
72.
Zurück zum Zitat Aronica SM, Katzenellenbogen BS: Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. Mol Endocrinol . 1993, 7: 743-752. 10.1210/me.7.6.743.PubMed Aronica SM, Katzenellenbogen BS: Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. Mol Endocrinol . 1993, 7: 743-752. 10.1210/me.7.6.743.PubMed
73.
Zurück zum Zitat Fujimoto N, Katzenellenbogen BS: Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: antiestrogen-selectivity and promoter-dependence. Mol Endocrinol. 1994, 8: 296-304. 10.1210/me.8.3.296.PubMed Fujimoto N, Katzenellenbogen BS: Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: antiestrogen-selectivity and promoter-dependence. Mol Endocrinol. 1994, 8: 296-304. 10.1210/me.8.3.296.PubMed
74.
Zurück zum Zitat Ignar-Trowbridge DM, Nelson KG, Bidwell MC, Curtis SW, Washburn TF, McLachlan JA, Korach KS: Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci USA. 1992, 89: 4658-4662.PubMedPubMedCentralCrossRef Ignar-Trowbridge DM, Nelson KG, Bidwell MC, Curtis SW, Washburn TF, McLachlan JA, Korach KS: Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci USA. 1992, 89: 4658-4662.PubMedPubMedCentralCrossRef
75.
Zurück zum Zitat Bunone G, Briand PA, Miksicek RJ, Picard D: Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 1996, 15: 2174-2183.PubMedPubMedCentral Bunone G, Briand PA, Miksicek RJ, Picard D: Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 1996, 15: 2174-2183.PubMedPubMedCentral
76.
Zurück zum Zitat Kato SH, Endoh Y, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masucshige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P: Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science. 1995, 270: 1491-1494.PubMedCrossRef Kato SH, Endoh Y, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masucshige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P: Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science. 1995, 270: 1491-1494.PubMedCrossRef
78.
Zurück zum Zitat Sheffield LG, Welsch CW: Cholera-toxin-enhanced growth of human breast cancer cell lines in vitro and in vivo: interaction with estrogen. Int J Cancer. 1985, 36: 479-483.PubMedCrossRef Sheffield LG, Welsch CW: Cholera-toxin-enhanced growth of human breast cancer cell lines in vitro and in vivo: interaction with estrogen. Int J Cancer. 1985, 36: 479-483.PubMedCrossRef
79.
Zurück zum Zitat Silberstein GB, Strickland PS, Trumpbour V, Coleman S, Daniel CW: cAMP stimulates growth and morphogenesis of mouse mammary ducts. Proc Natl Acad Sci USA. 1984, 81: 4950-4954.PubMedPubMedCentralCrossRef Silberstein GB, Strickland PS, Trumpbour V, Coleman S, Daniel CW: cAMP stimulates growth and morphogenesis of mouse mammary ducts. Proc Natl Acad Sci USA. 1984, 81: 4950-4954.PubMedPubMedCentralCrossRef
80.
Zurück zum Zitat Tremblay A, Tremblay GB, Labrie F, Giguere V: Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. Mol Cell. 1999, 3: 513-519.PubMedCrossRef Tremblay A, Tremblay GB, Labrie F, Giguere V: Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. Mol Cell. 1999, 3: 513-519.PubMedCrossRef
81.
Zurück zum Zitat Arnold SF, Obourn JD, Jaffe H, Notides AC: Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor. Mol Endocrinol. 1994, 8: 1208-1214. 10.1210/me.8.9.1208.PubMed Arnold SF, Obourn JD, Jaffe H, Notides AC: Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor. Mol Endocrinol. 1994, 8: 1208-1214. 10.1210/me.8.9.1208.PubMed
82.
Zurück zum Zitat LeGoff P, Montano MM, Schodin DJ, Katzenellenbogen BS: Phosphorylation of the human estrogen receptor: identification of hormone-regulated sites and examination of their influence on transcriptional activity. J Biol Chem. 1994, 269: 4458-4466. LeGoff P, Montano MM, Schodin DJ, Katzenellenbogen BS: Phosphorylation of the human estrogen receptor: identification of hormone-regulated sites and examination of their influence on transcriptional activity. J Biol Chem. 1994, 269: 4458-4466.
83.
Zurück zum Zitat Ali S, Metzger D, Bornert J-M, Chambon P: Phosphorylation of the human oestrogen receptor: identification of a phosphorylation site required for transactivation. EMBO J. 1993, 12: 1153-1160.PubMedPubMedCentral Ali S, Metzger D, Bornert J-M, Chambon P: Phosphorylation of the human oestrogen receptor: identification of a phosphorylation site required for transactivation. EMBO J. 1993, 12: 1153-1160.PubMedPubMedCentral
84.
Zurück zum Zitat Lahooti H, White R, Hoare SA, Rahman D, Pappin DJC, Parker MG: Identification of phosphorylation sites in the mouse oestrogen receptor. J Steroid Biochem Mol Biol. 1995, 55: 305-313. 10.1016/0960-0760(95)00188-3.PubMedCrossRef Lahooti H, White R, Hoare SA, Rahman D, Pappin DJC, Parker MG: Identification of phosphorylation sites in the mouse oestrogen receptor. J Steroid Biochem Mol Biol. 1995, 55: 305-313. 10.1016/0960-0760(95)00188-3.PubMedCrossRef
85.
Zurück zum Zitat Joel PB, Smith J, Sturgill TW, Fisher TL, Blenis J, Lannigan DA: pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167. Mol Cell Biol. 1998, 18: 1978-1984.PubMedPubMedCentralCrossRef Joel PB, Smith J, Sturgill TW, Fisher TL, Blenis J, Lannigan DA: pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167. Mol Cell Biol. 1998, 18: 1978-1984.PubMedPubMedCentralCrossRef
86.
Zurück zum Zitat Joel PB, Traish AM, Lannigan DA: Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase. J Biol Chem. 1998, 273: 13317-13323. 10.1074/jbc.273.21.13317.PubMedCrossRef Joel PB, Traish AM, Lannigan DA: Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase. J Biol Chem. 1998, 273: 13317-13323. 10.1074/jbc.273.21.13317.PubMedCrossRef
87.
Zurück zum Zitat Couse JF, Korach KS: Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr Rev. 1999, 20: 358-417. 10.1210/er.20.3.358.PubMedCrossRef Couse JF, Korach KS: Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr Rev. 1999, 20: 358-417. 10.1210/er.20.3.358.PubMedCrossRef
88.
Zurück zum Zitat Ediger TR, Kraus WL, Weinman EJ, Katzenellenbogen BS: Estrogen receptor regulation of the Na+/H+exchanger regulatory factor. Endocrinology. 1999, 140: 2976-2982. 10.1210/en.140.7.2976.PubMed Ediger TR, Kraus WL, Weinman EJ, Katzenellenbogen BS: Estrogen receptor regulation of the Na+/H+exchanger regulatory factor. Endocrinology. 1999, 140: 2976-2982. 10.1210/en.140.7.2976.PubMed
89.
Zurück zum Zitat Castoria G, Migliaccio A, Green S, Di Domenico M, Chambon P, Auricchio F: Properties of a purified estradiol-dependent calf uterus tyrosine kinase. Biochemistry. 1993, 32: 1740-1750.PubMedCrossRef Castoria G, Migliaccio A, Green S, Di Domenico M, Chambon P, Auricchio F: Properties of a purified estradiol-dependent calf uterus tyrosine kinase. Biochemistry. 1993, 32: 1740-1750.PubMedCrossRef
90.
Zurück zum Zitat Arnold SF, Vorojeikina DP, Notides AC: Phosphorylation of tyrosine 537 on the human estrogen receptor is required for binding to an estrogen response element. J Biol Chem. 1995, 270: 30205-30212. 10.1074/jbc.270.4.1850.PubMedCrossRef Arnold SF, Vorojeikina DP, Notides AC: Phosphorylation of tyrosine 537 on the human estrogen receptor is required for binding to an estrogen response element. J Biol Chem. 1995, 270: 30205-30212. 10.1074/jbc.270.4.1850.PubMedCrossRef
91.
Zurück zum Zitat Weis KE, Ekena K, Thomas JA, Lazennec G, Katzenellenbogen BS: Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. Mol Endocrinol. 1996, 10: 1388-1398. 10.1210/me.10.11.1388.PubMed Weis KE, Ekena K, Thomas JA, Lazennec G, Katzenellenbogen BS: Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. Mol Endocrinol. 1996, 10: 1388-1398. 10.1210/me.10.11.1388.PubMed
92.
Zurück zum Zitat White R, Sjoberg M, Kalkhoven E, Parker MG: Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine. EMBO J. 1997, 16: 1427-1435. 10.1093/emboj/16.6.1427.PubMedPubMedCentralCrossRef White R, Sjoberg M, Kalkhoven E, Parker MG: Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine. EMBO J. 1997, 16: 1427-1435. 10.1093/emboj/16.6.1427.PubMedPubMedCentralCrossRef
93.
Zurück zum Zitat Zhang Q-X, Borg A, Wolf DM, Oesterreich S, Fuqua SAW: An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer. Cancer Res. 1997, 57: 1244-1249.PubMed Zhang Q-X, Borg A, Wolf DM, Oesterreich S, Fuqua SAW: An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer. Cancer Res. 1997, 57: 1244-1249.PubMed
94.
Zurück zum Zitat Yudt MR, Vorojeikina D, Zhong L, Skafar DF, Sasson S, Gasiewicz TA, Notides AC: The function of estrogen receptor tyrosine 537 in hormone binding, DNA binding and transactivation. Biochemistry. 1999, 38: 14146-14156. 10.1021/bi9911132.PubMedCrossRef Yudt MR, Vorojeikina D, Zhong L, Skafar DF, Sasson S, Gasiewicz TA, Notides AC: The function of estrogen receptor tyrosine 537 in hormone binding, DNA binding and transactivation. Biochemistry. 1999, 38: 14146-14156. 10.1021/bi9911132.PubMedCrossRef
95.
Zurück zum Zitat Tremblay GB, Tremblay A, Labrie F, Giguere V: Ligand-independent activation of the estrogen receptors α and β by mutations of a conserved tyrosine can be abolished by antiestrogens. Cancer Res. 1998, 58: 877-881.PubMed Tremblay GB, Tremblay A, Labrie F, Giguere V: Ligand-independent activation of the estrogen receptors α and β by mutations of a conserved tyrosine can be abolished by antiestrogens. Cancer Res. 1998, 58: 877-881.PubMed
96.
Zurück zum Zitat Cho H, Katzenellenbogen BS: Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators. Mol Endocrinol. 1993, 7: 441-452. 10.1210/me.7.3.441.PubMed Cho H, Katzenellenbogen BS: Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators. Mol Endocrinol. 1993, 7: 441-452. 10.1210/me.7.3.441.PubMed
97.
Zurück zum Zitat Auricchio F, Migliaccio A, Castoria G, Di Domenico M, Bilancio A, Rotondi A: Protein tyrosine phosphorylation and estradiol action. Ann N Y Acad Sci. 1996, 784: 149-172.PubMedCrossRef Auricchio F, Migliaccio A, Castoria G, Di Domenico M, Bilancio A, Rotondi A: Protein tyrosine phosphorylation and estradiol action. Ann N Y Acad Sci. 1996, 784: 149-172.PubMedCrossRef
98.
Zurück zum Zitat Lieberherr M, Grosse B, Kachkache M, Balsan S: Cell signaling and estrogens in female rat osteoblasts: a possible involvement of unconventional nonnuclear receptors. J Bone Miner Res. 1993, 8: 1365-1376.PubMedCrossRef Lieberherr M, Grosse B, Kachkache M, Balsan S: Cell signaling and estrogens in female rat osteoblasts: a possible involvement of unconventional nonnuclear receptors. J Bone Miner Res. 1993, 8: 1365-1376.PubMedCrossRef
99.
Zurück zum Zitat Improta-Brears T, Whorton AR, Codazzi F, York JD, Meyer T, McDonnell DP: Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc Natl Acad Sci USA. 1999, 96: 4686-4691. 10.1073/pnas.96.8.4686.PubMedPubMedCentralCrossRef Improta-Brears T, Whorton AR, Codazzi F, York JD, Meyer T, McDonnell DP: Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc Natl Acad Sci USA. 1999, 96: 4686-4691. 10.1073/pnas.96.8.4686.PubMedPubMedCentralCrossRef
100.
Zurück zum Zitat Zhou Y, Watters JJ, Dorsa DM: Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain. Endocrinology. 1996, 137: 2163-2166. 10.1210/en.137.5.2163.PubMed Zhou Y, Watters JJ, Dorsa DM: Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain. Endocrinology. 1996, 137: 2163-2166. 10.1210/en.137.5.2163.PubMed
101.
Zurück zum Zitat Razandi M, Pedram A, Greene GL, Levin ER: Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in chinese hamster ovary cells. Mol Endocrinol. 1999, 13: 307-319. 10.1210/me.13.2.307.PubMed Razandi M, Pedram A, Greene GL, Levin ER: Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in chinese hamster ovary cells. Mol Endocrinol. 1999, 13: 307-319. 10.1210/me.13.2.307.PubMed
102.
Zurück zum Zitat Migliaccio A, Di Domenico M, Castoria G, de Flaco A, Bontempo P, Nola E, Auricchio F: Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 1996, 15: 1292-1300.PubMedPubMedCentral Migliaccio A, Di Domenico M, Castoria G, de Flaco A, Bontempo P, Nola E, Auricchio F: Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 1996, 15: 1292-1300.PubMedPubMedCentral
103.
Zurück zum Zitat Watson CS, Norfleet AM, Pappas TC, Gametchu B: Rapid actions of estrogens in GH3/B6 pituitary tumor cells via a plasma membrane version of estrogen receptor-alpha. Steroids. 1999, 64: 5-13. 10.1016/S0039-128X(98)00107-X.PubMedCrossRef Watson CS, Norfleet AM, Pappas TC, Gametchu B: Rapid actions of estrogens in GH3/B6 pituitary tumor cells via a plasma membrane version of estrogen receptor-alpha. Steroids. 1999, 64: 5-13. 10.1016/S0039-128X(98)00107-X.PubMedCrossRef
104.
Zurück zum Zitat Pappas TC, Gametchu B, Watson CS: Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J. 1995, 9: 404-410.PubMed Pappas TC, Gametchu B, Watson CS: Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J. 1995, 9: 404-410.PubMed
105.
Zurück zum Zitat Zheng J, Ramirez VD: Demonstration of membrane estrogen binding proteins in rat brain by ligand blotting using a 17β-estradiol-[125I] bovine serum albumin conjugate. J Steroid Biochem Mol Biol. 1997, 62: 327-336. 10.1016/S0960-0760(97)00037-X.PubMedCrossRef Zheng J, Ramirez VD: Demonstration of membrane estrogen binding proteins in rat brain by ligand blotting using a 17β-estradiol-[125I] bovine serum albumin conjugate. J Steroid Biochem Mol Biol. 1997, 62: 327-336. 10.1016/S0960-0760(97)00037-X.PubMedCrossRef
Metadaten
Titel
Estrogen receptor transcription and transactivation Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer
verfasst von
Benita S Katzenellenbogen
John A Katzenellenbogen
Publikationsdatum
01.10.2000
Verlag
BioMed Central
Erschienen in
Breast Cancer Research / Ausgabe 5/2000
Elektronische ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr78

Weitere Artikel der Ausgabe 5/2000

Breast Cancer Research 5/2000 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.